Appeal to Chimerix Inc to release a compassionate use dose of Brincidofovir to Josh Hardy to save his life.
When Josh Hardy was 9 months old, he was diagnosed with a malignant rhabdoid tumor of the kidneys. It’s a highly aggressive, rare form of cancer that only 15 children are diagnosed with each year. After receiving a bone marrow transplant he developed an adenovirus, an acute infection that has left Josh in the intensive care unit at St. Jude. The virus can be deadly for people, like Josh, who have a weak immune system. Chimerix Inc holds the medicine but is in phase three of clinical development. With the help of the FDA hopefully he can get the dose that may very well save his life.